Neuronetics is trading 7.94% up at $2.99 after no fresh company-specific catalyst was identified for September 3, 2026.

  • Latest confirmed developments were its August 11 second-quarter results and August 21 CFO appointment, both predating this move.
  • The broader market is relatively quiet, with S&P 500 futures down 0.07% and Nasdaq futures down 0.20%, so macro sentiment does not clearly explain the gain.